Generic Labeling “Carve-Outs” For Marinol Challenged On Safety Grounds

Solvay is asking FDA to prevent generic companies from using the "little eight" carve-out in their ANDAs for Marinol (dronabinol)

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet